Dofetilide
Back to searchMolecule Structure
Scientific Name
Dofetilide
Description of the Drug
Dofetilide is a class III antiarrhythmic drug used for the maintenance of normal sinus rhythm and cardioversion in cases of atrial fibrillation and atrial flutter.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00204
http://www.drugbank.ca/drugs/DB00204
Brand Name(s)
Dofetilide, Tikosyn
Company Owner(s)
Pfizer Pharmaceuticals Production Corp Ltd, Teva Pharmaceuticals Usa Inc, Msn Laboratories Private Ltd, Sigmapharm Laboratories Llc, Sun Pharmaceutical Industries Ltd, Prinston Pharmaceutical Inc, Mayne Pharma Inc, Novast Laboratories Ltd, Aurobindo Pharma Ltd, Accord Healthcare Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
HERG | SINGLE PROTEIN | BLOCKER | CHEMBL240 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL16135 | |
PharmGKB | PA449389 | |
Human Metabolome Database | HMDB0014349 | |
DrugBank | DB00204 | |
PubChem: Thomson Pharma | 14832836 | |
PubChem | 71329 | |
LINCS | LSM-5925 | |
Nikkaji | J291.759I | |
BindingDB | 50031720 | |
EPA CompTox Dashboard | DTXSID5046433 | |
DrugCentral | 942 | |
ChemicalBook | CB3381832 | |
Guide to Pharmacology | 2604 | |
rxnorm | DOFETILIDE | TIKOSYN |
PubChem: Drugs of the Future | 12014163 | |
KEGG Ligand | C07751 | |
ChEBI | 4681 | |
ZINC | ZINC000000596731 |